Analysts reiterated a positive stock rating for Penumbra, reported by MarketBeat.
1 report, 1 independent
Updated Jun 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analysts reiterated a positive stock rating for Penumbra, reported by MarketBeat.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Penumbra
medical device company in Alameda, California
-
MarketBeat
American personal finance blog